Further evidence supporting the importance of fatty acid oxidation in AML is seen in studies relating to the enzyme carnitine palmitoyltransferase I (CPT1), which catalyzes the rate limiting step of the carnitine shuttle component of fatty acid oxidation (9, 51, 52). This evidence concerns the gene CPT1C and acute myeloid leukemia.